Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

The modernized Technical Bulletin website is here!
Read more about the modernization release schedule in this announcement. Contact the NLM Help Desk with any questions or concerns.
Return to old site

RxNorm September 2024 Monthly Release

RxNorm September 2024 Monthly Release. NLM Tech Bull. 2024 Sep-Oct;(460):b3.

September 05, 2024 [posted]

The RxNorm September 2024 monthly release became available on Tuesday, September 3, 2024. This release includes updated COVID-19 vaccines.

The U.S. Food and Drug Administration (FDA) approved and authorized for emergency use updated COVID-19 vaccines formulated to better protect against currently circulating variants (FDA news release).

Here are the new RxNorm COVID-19-related concepts:

Moderna EUA

  • RXCUI 2691172: 0.25 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe

Pfizer-BioNTech EUA

  • RXCUI 2691196: SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension
  • RXCUI 2691200: 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 MG/ML Injection

Comirnaty

  • RXCUI 2691212: 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Comirnaty 2024-2025]
  • RXCUI 2691219: 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Injection [Comirnaty 2024-2025] 

Spikevax

  • RXCUI 2691189: 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Injection [Spikevax 2024-2025]
  • RXCUI 2691181: 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Spikevax 2024-2025]

Get more information about Emergency Use Authorization (EUA) from the FDA.

Get more information about RxNorm’s policy change on investigational drugs from the National Library of Medicine.